Compounded semaglutide is not FDA approved and carries real risks because it sits outside the quality system that governs Ozempic and Wegovy. It can be legal under narrow compounding rules, but that legality hinges on details most buyers never check: whether a genuine shortage exists, whether the pharmacy uses the true active ingredient or a cheaper salt, and whether a licensed clinician actually wrote the prescription. Safety concerns cluster around three things that go wrong again and again with injectable compounds: potency, sterility, and dosing errors. The short version is that compounded semaglutide is neither automatically illegal nor automatically dangerous, but it demands a level of scrutiny that the marketing around it almost never encourages. This guide walks through the legal line, the specific failure points, and the questions that separate a legitimate compounding pharmacy from a website that will ship you an unlabeled vial.

Key Takeaways

  • Compounded semaglutide is not FDA approved and is not a generic version of Ozempic or Wegovy. A generic is an approved copy; a compound is a custom preparation the FDA never reviews.
  • Legal compounding is allowed only under specific conditions, most often a documented medical need the approved product cannot meet, and historically during an official drug shortage.
  • Major safety risks include contamination, incorrect potency, and use of unapproved semaglutide salts rather than the base drug.
  • The FDA has received reports of adverse events linked to compounded semaglutide, including dosing errors and infections.
  • The legal landscape shifted once the FDA declared the semaglutide shortage resolved in early 2025, which narrowed the grounds for large-scale compounding.
  • Patients should verify that the pharmacy is licensed, accredited, uses FDA registered base ingredients, and dispenses only against a valid prescription.

What Is Compounded Semaglutide?

The simplest way to actually get this done

Superpower is a full-body lab membership that runs 100+ biomarkers, has each result reviewed by a doctor, and tracks your numbers year over year (about $199/year). It is what we point readers to when they would rather get one clean, complete draw than chase single tests one at a time. Here is superpower reviewed in full.

Check current Superpower pricing →

Compounded semaglutide is a custom made version of the active ingredient in Ozempic and Wegovy, prepared by a compounding pharmacy. Unlike the brand name drugs, which are FDA approved and manufactured under strict quality controls, compounded versions are not reviewed by the FDA for safety, effectiveness, or quality. Compounding pharmacies are allowed to create a drug when a patient has a specific medical need that cannot be met by an approved product, such as an allergy to an inactive ingredient or a need for a different dosage strength. However, the recent surge in demand for semaglutide has led many pharmacies to compound it for general weight loss, often without a valid medical justification.

The word compounding covers two very different operations, and knowing which one you are dealing with matters. Traditional pharmacies operate under section 503A of the federal Food, Drug, and Cosmetic Act. They compound for an individual patient against an individual prescription, and they are overseen mainly by state boards of pharmacy rather than by federal inspectors. Outsourcing facilities operate under section 503B. They can make larger batches without a patient specific prescription, but in exchange they register with the FDA, submit to federal inspection, and follow a stricter set of manufacturing rules. When a telehealth company advertises cheap semaglutide, it is usually sourcing from one of these two channels, and a 503B facility generally carries more oversight than a small 503A pharmacy you have never heard of.

It also helps to be precise about what a compound is not. It is not a generic. A generic drug is an approved product that has proven it delivers the same active ingredient into the bloodstream in the same way as the brand, and it carries the same FDA guarantees. There is currently no generic semaglutide in the United States because the patents have not expired. So any semaglutide sold for a fraction of the brand price is either a compound, a research chemical sold illegally as if it were a drug, or a counterfeit. The label alone will not tell you which, which is why the sourcing questions later in this article matter more than the price.

Is Compounded Semaglutide Legal?

Compounded semaglutide can be legal under federal and state pharmacy laws, but only when certain conditions are met. The FDA allows compounding from bulk drug substances when the drug is not commercially available in the exact form needed for a specific patient. However, the agency has warned that many compounded semaglutide products are being made from semaglutide salts, such as semaglutide sodium or semaglutide acetate, which are not the same active ingredient used in the approved drugs. The FDA considers these salt forms to be new, unapproved drugs and has stated that they should not be compounded. As a result, any compounded semaglutide made from a salt form is technically illegal. Pharmacies that use the same base ingredient as the brand name drug may be operating legally, but the FDA still does not review their products for safety.

The single biggest legal lever is the drug shortage list. For most of the demand surge, semaglutide and its cousin tirzepatide sat on the FDA shortage list, and that status is what gave compounders their broadest legal footing, because compounding a copy of an approved drug is generally prohibited unless that drug is in shortage. That door began to close in early 2025. The FDA declared the tirzepatide shortage resolved and then, in February 2025, declared the semaglutide shortage resolved as well. Resolving a shortage does not flip an instant switch, so the agency set wind-down windows: smaller 503A pharmacies and the larger 503B outsourcing facilities were each given a defined grace period, after which continuing to compound copies would no longer be protected. The practical takeaway is that the legal ground under mass-market compounded semaglutide is far shakier now than it was during the height of the shortage.

Legality also lives at the state level, and this is where many buyers get caught. A pharmacy must be licensed in the state where the patient lives, not just in the state where it operates. A prescription must come from a clinician licensed to treat that patient, after a real evaluation. And the drug must be dispensed for an individual, not sold like a supplement off a web store. A site that lets you add semaglutide to a cart, skip any medical review, and check out with a card is not doing legal compounding regardless of what its footer claims. When people ask whether compounded semaglutide is legal, the honest answer is that it depends less on the molecule and more on the paper trail behind the specific vial in your hand.

Is Compounded Semaglutide Safe?

Compounded semaglutide is not considered safe by the FDA because it lacks the same quality controls as approved medications. The agency has received reports of serious adverse events, including gastrointestinal distress, infections at injection sites, and hospitalizations due to dosing errors. One major concern is that compounded products may contain too much or too little active ingredient. A 2023 FDA analysis of several compounded semaglutide samples found that some did not contain any semaglutide at all, while others contained impurities or incorrect concentrations. Without standardized manufacturing, patients cannot be sure they are getting a safe, effective product. Additionally, the use of unapproved semaglutide salts raises further safety questions because these compounds have not been studied in humans.

The dosing-error problem deserves special attention because it is the one most likely to send someone to the emergency room. Approved Wegovy and Ozempic come in prefilled pens calibrated to deliver an exact dose with a click. Many compounded products arrive as a multi-dose vial plus a syringe, and the patient has to draw up the correct volume themselves. State poison control centers reported a sharp rise in semaglutide-related calls as compounded use spread, and a large share of those calls traced back to people measuring in the wrong units, confusing milligrams with milliliters, or misreading a syringe marked in units meant for insulin. A tenfold overdose of a GLP-1 drug is not a mild event. It can cause relentless vomiting, dehydration, and dangerous swings in blood sugar. The molecule may be identical to the approved drug, but the delivery format quietly transfers a lot of risk onto the person at the kitchen table.

Sterility is the other quiet danger. Semaglutide is injected under the skin, so anything living in the vial goes into your body. Approved manufacturing runs under validated sterile processes with batch testing before release. A compounding operation is supposed to follow United States Pharmacopeia sterile standards, but adherence varies, and the buyer has no way to inspect the clean room. When sterility fails, the result can be a local abscess at the injection site or, in the worst cases, a bloodstream infection. This is precisely why sourcing from an accredited facility, rather than the cheapest link in a social media ad, is not a nicety but the core of harm reduction.

For a detailed overview of how GLP-1 medications like semaglutide work in the body, see our guide: GLP-1 Medications Explained.

What Are the Specific Risks of Compounded Semaglutide?

The risks of compounded semaglutide fall into several categories. First, contamination is possible if the pharmacy does not maintain sterile conditions. Since semaglutide is injected, any bacterial or fungal contamination can cause serious infections. Second, potency errors are common. A study published in JAMA Internal Medicine in 2024 found that compounded semaglutide from several online pharmacies contained between 67% and 138% of the labeled amount of drug. Third, patients may receive a completely different substance. The FDA has warned that some products labeled as semaglutide actually contained insulin or other drugs, leading to dangerous drops in blood sugar. Fourth, the use of semaglutide salts means the drug may not be absorbed or metabolized the same way as the approved version, increasing the risk of unexpected side effects.

Beyond those four, there are risks that show up only once you are already using the product. Additives are one. A legitimate injectable is a short list of well characterized ingredients, but some compounded blends add vitamins, amino acids, or other agents marketed as fat-burning enhancers, and each addition is a new variable that has never been tested in that combination. Storage and shipping are another. Peptide drugs are sensitive to heat, and a vial that spends two days in a hot delivery truck can degrade in ways you cannot see, so the actual dose you inject may be lower than the label even if the pharmacy filled it correctly. Finally, there is the traceability risk. If a batch turns out to be contaminated or mislabeled, an approved drug can be recalled through a formal system that reaches every patient. A compound bought from an anonymous site has no such safety net, and you may never learn there was a problem.

How Can You Tell if a Compounded Product Is Legitimate?

Because the label will not protect you, the vetting has to happen before you ever inject. Treat the following as a checklist, and treat a no on any single item as a reason to walk away rather than a detail to overlook.

  • The pharmacy is licensed in your state and, ideally, accredited by the Pharmacy Compounding Accreditation Board or the Joint Commission. You can confirm state licensure through the state board of pharmacy website.
  • A prescription comes from a clinician who evaluated you, not from a checkout button. If no one asked about your medical history, that is a red flag, not a convenience.
  • The product uses semaglutide base, the same active ingredient as the brand, and not a salt form such as semaglutide sodium or semaglutide acetate.
  • The pharmacy will provide a certificate of analysis for the specific batch, showing tested potency and purity from an independent lab.
  • The medication arrives properly labeled, with the drug name, concentration, lot number, and a beyond-use date, and it ships with cold-chain packaging appropriate to a peptide.
  • The price is not implausibly cheap. A dose that costs a small fraction of the approved drug should raise suspicion about what is really in the vial.

A quick scenario shows how this plays out. Imagine two options at similar prices. One is a telehealth clinic that requires a video visit, reviews your labs, ships a labeled vial with a batch certificate, and lists a licensed pharmacy. The other is an Instagram account that DMs you a payment link and promises next-day shipping with no questions. The molecule advertised is the same. Everything that determines whether it is safe and legal is different. The vetting, not the ingredient, is the product you are actually buying.

How Can You Reduce Risk if You Use Compounded Semaglutide?

If you and your doctor decide that compounded semaglutide is your best option, you can take steps to reduce risk. First, only use a pharmacy that is accredited by the Pharmacy Compounding Accreditation Board or a state board of pharmacy. Second, ask the pharmacist whether the product uses the same active ingredient as the brand name drug (semaglutide base) or a salt form. Avoid any product made from a salt. Third, request a certificate of analysis showing that the pharmacy tests each batch for potency and purity. Fourth, never buy semaglutide from an online source that does not require a prescription. Many illegal sellers operate online and sell counterfeit or contaminated products. Finally, report any adverse effects to the FDA MedWatch program to help regulators track safety issues.

Two habits reduce risk further once you have a legitimate product. Get your dosing plan in writing and confirm the units. Ask the prescriber to tell you exactly how many milligrams you should inject and exactly how many marks on the specific syringe that equals, then have them confirm your first dose. Do not translate a dose from an internet forum. Second, treat the start of therapy as a monitoring period, not a set-and-forget. Watch for signs that call for a pause and a phone call: severe or persistent vomiting, signs of dehydration, redness or swelling at the injection site, or symptoms of low blood sugar such as shakiness and confusion. GLP-1 drugs work by slowing the gut and blunting appetite, so a degree of nausea is expected, but the difference between an expected side effect and an emergency is a conversation worth having with a clinician who knows your case.

What Does the FDA Say About Compounded Semaglutide?

The FDA has issued multiple warnings about compounded semaglutide. In May 2023 and again in 2024, the agency stated that it has not evaluated any compounded semaglutide for safety or effectiveness. The FDA also clarified that semaglutide is not on the drug shortage list in its approved form, which limits the legal basis for compounding. While the FDA does not directly regulate compounding pharmacies on a day to day basis, it has the authority to take action against those that produce unsafe products. The agency has sent warning letters to several pharmacies for making unsubstantiated claims about compounded semaglutide and for using unapproved ingredients. Patients should be aware that the FDA does not endorse any compounded version of this drug.

The agency has also been explicit about the salt issue and about counterfeits. It placed semaglutide salts outside the categories it will allow compounders to use, on the grounds that these are effectively unstudied new drugs. Separately, it has warned about counterfeit Ozempic entering the supply chain, with fake pens carrying incorrect needles and unverified contents. The through-line in all of the FDA’s messaging is consistent: an approved product carries a chain of accountability from factory to pharmacy, and stepping outside that chain, whether through a compound, a research chemical, or a counterfeit, removes protections that are easy to take for granted until something goes wrong.

Want a real clinician to run the numbers, not a guess?

Joi + Blokes is a telehealth clinic that prescribes GLP-1 medication (Zepbound, compounded semaglutide and tirzepatide), hormone therapy (TRT, HRT), thyroid care, and peptides after a real lab panel and clinician review, with no membership or consult fee (prescriptions from about $59/month, lab panels from $149). If the scale will not budge, this is where you find out whether insulin, thyroid, or hormones are the real reason. Here is Joi + Blokes reviewed in full.

See Joi + Blokes pricing →

Frequently Asked Questions

Can I trust compounded semaglutide from an online pharmacy?

You should be very cautious about online pharmacies selling compounded semaglutide. Many are not licensed in the United States and may sell counterfeit or contaminated products. Legitimate compounding pharmacies require a valid prescription from your doctor and will not offer to prescribe the drug themselves. Before ordering, verify that the pharmacy is licensed in your state and accredited by a recognized organization. Avoid any website that does not ask for a prescription or that promises quick, cheap semaglutide without a consultation.

What should I look for in a compounding pharmacy?

Look for a pharmacy that is accredited by the Pharmacy Compounding Accreditation Board or the Joint Commission. The pharmacy should be willing to provide a certificate of analysis for each batch of compounded semaglutide. Ask whether they use the same semaglutide base as the brand name drug, not a salt form. Also confirm that the pharmacy follows United States Pharmacopeia standards for sterile compounding. Your doctor or local health department can help you find a reputable compounding pharmacy in your area.

Are there alternatives to compounded semaglutide?

Yes, there are several FDA approved alternatives. Ozempic and Wegovy (semaglutide) are available for diabetes and weight loss, respectively, though they may be expensive or have limited insurance coverage. Other approved GLP-1 receptor agonists include liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound). These drugs have been studied extensively and are manufactured under strict quality controls. If cost is a concern, some manufacturers offer patient assistance programs. You can also discuss lifestyle interventions and other weight loss medications with your doctor. Compounded semaglutide should only be considered when no approved alternative is suitable for your specific medical needs.

Now that the shortage is over, is compounded semaglutide still available?

Access has tightened. Once the FDA declared the semaglutide shortage resolved in early 2025 and the wind-down periods passed, the broad legal basis that allowed pharmacies to compound copies of the approved drug largely fell away. Some compounding may still occur for genuinely individualized medical needs that an approved product cannot meet, but the era of mass-market compounded semaglutide sold like a subscription is on much thinner ice. If a site is still selling it freely and cheaply, that is a reason for more scrutiny, not less.

Is compounded semaglutide the same strength as Ozempic or Wegovy?

Not necessarily. Approved pens deliver a precise, validated dose. A compounded vial depends entirely on how accurately the pharmacy prepared it, and testing has found real products ranging both above and below their labeled amount. That variability is why a certificate of analysis for the specific batch matters, and why you should never assume a compounded milligram behaves like a brand-name milligram.

What should I do if I have a bad reaction?

Stop and seek care based on severity. For severe vomiting, signs of dehydration, chest pain, a spreading infection at the injection site, or symptoms of very low blood sugar, seek urgent medical attention. For milder issues, contact the prescribing clinician before your next dose. In all cases, report the event to the FDA MedWatch program, which is how regulators detect patterns of harm from specific products and pharmacies.

This article is for general information and is not medical advice. See our Medical Disclaimer.